Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index

INTRODUCTION: Lung squamous cell carcinoma (LUSC) is a unique subform of nonsmall cell lung cancer (NSCLC). The lack of specific driver genes as therapeutic targets leads to worse prognoses in patients with LUSC, even with chemotherapy, radiotherapy, or immune checkpoint inhibitors. Furthermore, res...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Rihan, Ma, Ru, Duan, Xiaojun, Zhang, Jiandong, Li, Kexin, Yu, Lei, Zhang, Mingyang, Liu, Pengxia, Wang, Changshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570622/
https://www.ncbi.nlm.nih.gov/pubmed/37841237
http://dx.doi.org/10.3389/fimmu.2023.1236444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570622/
https://www.ncbi.nlm.nih.gov/pubmed/37841237
http://dx.doi.org/10.3389/fimmu.2023.1236444

Ejemplares similares